-
Jan 6, 2025 | 
bpspubs.onlinelibrary.wiley.com | Ryosuke Sato |Stephan von Haehling |Selby AL
1 INTRODUCTION Cancer cachexia (CC) is a multifactorial syndrome characterized by a progressive decline in body weight, malnutrition, diminished skeletal muscle mass, frequent loss of fat mass, and impaired functional capacity.1 CC has been associated with increased treatment-related toxicity, hospitalization, and reduced survival in patients with cancer.2 In addition, CC is highly prevalent and is described to affect up to 80% of patients with advanced cancer, predominantly those with solid...
-
Oct 14, 2024 | 
bpspubs.onlinelibrary.wiley.com | Brian Carson |Stephan von Haehling |Selby AL |Beatriz R. Goes-Santos
AA amino acids ALA α-linolenic acid BCAAs branched-chain amino acids BWPH blue whiting-derived protein hydrolysate DHA docosahexaenoic acid EAA essential amino acids EPA eicosapentaenoic acid MPB muscle protein breakdown MPS muscle protein synthesis mTOR mammalian target of rapamycin PUFA polyunsaturated fatty acid RDA recommend day allowanced WP whey protein ω-3 omega 3 1 INTRODUCTION Sarcopenia is defined as a generalized skeletal muscle disorder associated with loss of muscle strength,...
-
Oct 5, 2024 | 
academic.oup.com | Dilek Ural |Nicolle Kränkel |Daniela Pedicino |Stephan von Haehling
Oxford University Press uses cookies to enhance your experience on our website. By selecting ‘accept all’ you are agreeing to our use of cookies. You can change your cookie settings at any time. More information can be found in our Cookie Policy.
-
Jun 17, 2024 | 
heart.bmj.com | Ryosuke Sato |Frauke Czepluch |Stephan von Haehling
Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
-
May 21, 2024 | 
heart.bmj.com | Ryosuke Sato |Stephan von Haehling |Frauke Czepluch
Statistics from Altmetric.com Request Permissions If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
-
May 10, 2024 | .html&sz=64)
fis.uke.de | Stephan von Haehling |Georg-August-University Göttingen |Wolfram Doehner |Ruben Evertz
BACKGROUND AND AIMS: Evidence is lacking that correcting iron deficiency (ID) has clinically important benefits for patients with heart failure with preserved ejection fraction (HFpEF). METHODS: FAIR-HFpEF was a multicentre, randomized, double-blind trial designed to compare intravenous ferric carboxymaltose (FCM) with placebo (saline) in 200 patients with symptomatic HFpEF and ID (serum ferritin < 100 ng/mL or ferritin 100-299 ng/mL with transferrin saturation < 20%).
-
Feb 26, 2024 | 
onlinelibrary.wiley.com | Magnus Bäck |Stephan von Haehling |Zoltán Papp |Massimo F. Piepoli
Introduction The ESC Heart Failure journal was launched by the Heart Failure Association of the European Society of Cardiology (ESC) in 2014, hence it became a teenager in 2024. By recognizing the need for a heart failure specific scientific platform, broader than available back in 2014, ESC Heart Failure has been initiated as the first open access ESC journal to gather contributions from a spectrum of heart failure related research areas.
-
Jan 30, 2024 | 
onlinelibrary.wiley.com | Stefan Anker |Stephan von Haehling |Hsi-Yu Lai |Shih-Tsung Huang
Introduction Ageing is a multifaceted process involving the concomitant development of diseases, functional limitations and social vulnerability that present challenges in disease management and outcome prediction.1 Heart failure (HF), a prevalent condition among older adults, exemplifies how age-related conditions, such as frailty, heavily influence the clinical course.
-
Dec 26, 2023 | 
onlinelibrary.wiley.com | Stephan von Haehling |Andrew Coats |Stefan Anker
The Journal of Cachexia, Sarcopenia and Muscle (JCSM) is a peer-reviewed international journal dedicated to publishing materials that are related to cachexia and sarcopenia as well as to body composition and its physiological and pathophysiological changes during the life span and in different illnesses from all fields of the life sciences.
-
Nov 6, 2023 | 00197-7/fulltext&sz=64)
thelancet.com | Fabian Kerwagen |Rolf Wachter |Stephan von Haehling |Uwe Riemer
Research in contextGuideline-directed medical therapy (GDMT) is the cornerstone of a successful treatment strategy in patients with heart failure and reduced ejection fraction (HFrEF). Besides established pharmacotherapy, novel substances such as sacubitril/valsartan (S/V) and sodium-glucose co-transporter-2 inhibitors (SGLT2i) have demonstrated marked clinical benefits.
